We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

193 hedge funds and large institutions have $90.9M invested in Editas Medicine in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 48 increasing their positions, 52 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

207% more call options, than puts

Call options by funds: $1.83M | Put options by funds: $596K

78% more capital invested

Capital invested by funds: $51M → $90.9M (+$39.9M)

0% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 26

1% less funds holding

Funds holding: 194 → 193 (-1)

8% less repeat investments, than reductions

Existing positions increased: 48 | Existing positions reduced: 52

3.69% less ownership

Funds ownership: 53.03% → 49.34% (-3.7%)

Holders
193
Holders Change
-1
Holders Change %
-0.52%
% of All Funds
2.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
48
Reduced
52
Closed
26
Calls
$1.83M
Puts
$596K
Net Calls
+$1.24M
Net Calls Change
+$907K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$2.6M
2
WP
Woodline Partners
California
+$1.38M
3
N
Nuveen
North Carolina
+$1.04M
4
Citadel Advisors
Citadel Advisors
Florida
+$854K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$587K

Top Sellers

Rank Fund Capital Flow
1
UBS AM
UBS AM
Illinois
-$3.02M
2
Morgan Stanley
Morgan Stanley
New York
-$2.03M
3
UBS Group
UBS Group
Switzerland
-$959K
4
Bank of America
Bank of America
North Carolina
-$717K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
SOW
51
State of Wyoming
Wyoming
$146K +$36.1K +22,069 +50%
Citigroup
52
Citigroup
New York
$132K -$5.35K -3,272 -5%
Wealth Enhancement Advisory Services
53
Wealth Enhancement Advisory Services
Minnesota
$131K +$9.96K +6,088 +14%
HSBC Holdings
54
HSBC Holdings
United Kingdom
$122K -$8.65K -5,285 -9%
Mariner
55
Mariner
Kansas
$118K +$52.3K +31,959 +147%
T. Rowe Price Associates
56
T. Rowe Price Associates
Maryland
$117K +$15.3K +9,360 +21%
MIM
57
MetLife Investment Management
New Jersey
$114K +$85K +51,955 New
Mirae Asset Global ETFs Holdings
58
Mirae Asset Global ETFs Holdings
Hong Kong
$104K -$198K -121,307 -72%
IIM
59
INTECH Investment Management
Florida
$104K -$44.9K -27,414 -37%
AC
60
AXQ Capital
New Jersey
$104K +$77K +47,083 New
Carson Wealth (CWM LLC)
61
Carson Wealth (CWM LLC)
Nebraska
$98K -$4.84K -2,959 -6%
MML Investors Services
62
MML Investors Services
Massachusetts
$97K +$15.3K +9,373 +27%
LPL Financial
63
LPL Financial
California
$96.6K -$4.18K -2,556 -5%
VPIM
64
Vanguard Personalized Indexing Management
California
$91K +$24.2K +14,765 +56%
GCM
65
Graham Capital Management
Connecticut
$89.4K +$66.5K +40,633 New
SCM
66
SCS Capital Management
Massachusetts
$77K – – –
B
67
Bailard
California
$74.5K – – –
TWM
68
Thrive Wealth Management
Pennsylvania
$73.7K – – –
PCIA
69
Prime Capital Investment Advisors
Kansas
$71K -$25.5K -15,588 -33%
IAIM
70
International Assets Investment Management
Florida
$70.4K +$52.4K +32,007 New
Canada Life
71
Canada Life
Manitoba, Canada
$70K +$38.5K +23,513 +279%
DIM
72
DLK Investment Management
California
$67.6K – – –
HKAM
73
Horizon Kinetics Asset Management
New York
$66.9K -$2.18K -1,330 -4%
Manulife (Manufacturers Life Insurance)
74
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$65K -$6.88K -4,203 -12%
Baird Financial Group
75
Baird Financial Group
Wisconsin
$63.5K -$3.08K -1,880 -6%
1 2
3
4 5

EDIT Hedge Fund Activity: Q2 2025 in Review

193 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2025, worth a combined $90.9M — up 78% from $51M a quarter earlier.

Fund positioning in EDIT was balanced in Q2 2025: 26 funds opened new positions, 26 closed out, 48 added to existing stakes and 52 trimmed.

The largest buyer was Millennium Management, adding an estimated $2.6M. The largest seller was UBS AM, exiting entirely with an estimated $3.02M sold.

  • 193 institutional investors held Editas Medicine (EDIT) as of Q2 2025, down from 194 in Q1 2025.
  • Funds reported $90.9M of Editas Medicine stock for Q2 2025, up 78% quarter-over-quarter.
  • 26 funds opened new Editas Medicine positions in Q2 2025 and 26 closed out, a net change of 0 holders.
  • The largest Editas Medicine buyer in Q2 2025 was Millennium Management, an estimated $2.6M added.
  • The largest Editas Medicine seller in Q2 2025 was UBS AM, an estimated $3.02M sold.

Based on aggregated 13F filings for Q2 2025.